Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18611
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarselos, M.en
dc.contributor.authorTorronen, R.en
dc.contributor.authorAitio, A.en
dc.date.accessioned2015-11-24T18:53:49Z-
dc.date.available2015-11-24T18:53:49Z-
dc.identifier.issn0049-8254-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18611-
dc.rightsDefault Licence-
dc.subjectAnimalsen
dc.subjectAscorbic Acid/urineen
dc.subjectDioxins/*pharmacologyen
dc.subjectGlucaric Acid/urineen
dc.subjectGlucuronates/*metabolismen
dc.subjectIntestine, Small/metabolismen
dc.subjectKidney/metabolismen
dc.subjectLiver/enzymology/metabolismen
dc.subjectMaleen
dc.subjectPhospholipids/metabolismen
dc.subjectProteins/metabolismen
dc.subjectRatsen
dc.subjectTetrachlorodibenzodioxin/*pharmacologyen
dc.titleResponses of the D-glucuronic acid pathway in rat tissues to treatment with tetrachlorodibenzodioxinen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/685288-
heal.identifier.secondaryhttp://informahealthcare.com/doi/abs/10.3109/00498257809070023-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1978-
heal.abstract1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) was administered to rats to study its effects on the enzyme activities of the D-glucuronic acid pathway in the liver, small intestine and kidney. 2. The UDP-glucuronosyl transferase activity of male albino rats given TCDD (80 mug/kg, one dose, i.p.) 6 days before killing was significantly increased in all tissues examined, and UDP-glucuronic acid pyrophosphatase activity was markedly decreased in the liver. D-Glucuronolactone and L-gulonate dehydrogenase activities in the liver and small intestine were slightly decreased after TCDD treatment. 3. The activities of UDP-glucose dehydrogenase and beta-glucuronidase were unchanged. 4. The 24 h urinary excretion of L-ascorbic acid was enhanced 8-fold, although no difference was detected in the excretion of D-glucaric acid between the control and experimental animals. 5. These results suggest an increased capacity for glucuronide conjugation after treatment with TCDD. 6. The lack of increase in the urinary excretion of D-glucaric acid further challenges its use as a reliable indicator of enhanced drug metabolism.en
heal.journalNameXenobioticaen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons